InvestorsHub Logo
Followers 1
Posts 349
Boards Moderated 0
Alias Born 07/16/2014

Re: duderaja post# 3253

Thursday, 03/24/2022 3:32:19 PM

Thursday, March 24, 2022 3:32:19 PM

Post# of 3504
The bottom line is the drug will work for crohn's disease with no side effects. However, they have no money to do the Phase 3 trials. Not sure how far 5.7 million will get them. They will probably continue to need to raise more so further dilution will occur. This is a long term play but how it all works out no one knows for sure.